ADCE-202

N/A

Report date: 2025/07/10 11:35:58

Base Information

Drug NameADCE-202

Drug Alias NameADCE-202

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker

Mechanisms of ActionAnti-C-type mannose receptor 2DNA topoisomerase I inhibitors

TargetsC-type mannose receptor 2DNA topoisomerase I

Therapy Area/IndicationsSarcoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAdcendo APS

China Registration ClassN/A

Develop Information

Active CompaniesAdcendo APS

Inactive CompaniesN/A

Active IndicationsSarcoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A